Annabidiol Corp. (ACBD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Annabidiol Corp. (ACBD) trades at $0.84 with AI Score 51/100 (Grade B). Annabidiol Corp. is a shell company based in Marblehead, Massachusetts, with no significant operations. Market cap: $33.76M, Sector: Financial services.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for ACBD: ACBD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ACBD against Financial Services peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
ACBD: the 6 perspectives are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →Annabidiol Corp. (ACBD) Financial Services Profile
Annabidiol Corp., a shell company incorporated in 2009, lacks significant operations and seeks asset acquisitions and strategic partnerships. Previously in telecommunications, the company's current focus remains unclear, operating within the financial services sector with a negative beta of -1.17 and a high P/E ratio of -254.20.
What Is the Investment Thesis for ACBD?
Annabidiol Corp. presents a speculative investment opportunity due to its status as a shell company. The company's strategy focuses on identifying and executing asset acquisitions, strategic partnerships, and joint ventures. Key value drivers depend on the successful identification and integration of viable business opportunities. A potential catalyst is the announcement of a significant acquisition or partnership that could drive investor interest. However, the investment carries substantial risk due to the lack of current operations and reliance on future, uncertain transactions. The company's negative P/E ratio of -254.20 reflects its current lack of profitability. The negative beta of -1.17 suggests an inverse correlation with market movements, although this may not be reliable given the company's limited activity.
Based on FMP financials and quantitative analysis
ACBD Key Highlights
- Market capitalization of $33.76M indicates a micro-cap company.
- P/E ratio of -254.20 reflects current lack of profitability.
- Negative beta of -1.17 suggests an inverse correlation with market movements.
- No dividend yield, as the company does not currently distribute dividends.
- Focus on asset acquisitions, strategic partnerships, and joint ventures as a core strategy.
Who Are ACBD's Competitors?
ACBD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ABVN ABV Consulting, Inc. | $3.50 | +133.33% | $19.37M | 44 |
| BOREF Borealis Exploration Limited | $2.00 | +0.00% | $9.91M | 44 |
| NSH NavSight Holdings, Inc. | $9.93 | +3.01% | 69 | |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.39M | 68 |
| LMAOU LMF Acquisition Opportunities, Inc. | $12.46 | +41.59% | 68 | |
| APXTW Apex Treasury Corporation | $0.35 | +11.59% | $1.88B | 66 |
| RTP Reinvent Technology Partners | $10.03 | -4.48% | $6.30B | 57 |
| ROCGU Roth CH Acquisition IV Co. | $10.29 | +2.90% | $57.15M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ACBD's Key Strengths?
- Flexibility to pursue various acquisition opportunities.
- Potential for high returns if acquisitions are successful.
- Existing corporate structure and listing.
What Are ACBD's Weaknesses?
- Lack of current operations and revenue.
- Reliance on future acquisitions for growth.
- High dependence on management's deal-making abilities.
What Could Drive ACBD Stock Higher?
- Announcement of a strategic partnership or joint venture.
- Identification of a potential acquisition target.
- Efforts to raise capital for future acquisitions.
What Are the Key Risks for ACBD?
- Financial-distress signal — its Altman Z-Score of -37.10 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Failure to identify and execute successful acquisitions.
- Competition from other shell companies and SPACs.
- Changes in market conditions or regulatory environment.
- Limited operating history and revenue generation.
- Dependence on management's deal-making abilities.
What Are the Growth Opportunities for ACBD?
- Strategic Acquisition: Annabidiol Corp. has the opportunity to acquire a promising private company, providing it with immediate operations and revenue streams. The market for acquisitions is substantial, with billions of dollars in deals occurring annually. A successful acquisition could transform Annabidiol Corp. into an operating entity with growth potential. Timeline: Within the next 1-2 years.
- Joint Venture Formation: Forming a joint venture with an established company in a high-growth sector could provide Annabidiol Corp. with access to new markets and technologies. The joint venture market is robust, with numerous opportunities across various industries. A well-structured joint venture could create significant value for Annabidiol Corp. Timeline: Within the next 1-2 years.
- Strategic Partnership: Establishing a strategic partnership with a company possessing complementary assets or expertise could enhance Annabidiol Corp.'s ability to identify and execute acquisitions. Strategic partnerships can provide access to deal flow and due diligence capabilities. Timeline: Ongoing.
- Capital Raise: Successfully raising capital through a private placement or public offering could provide Annabidiol Corp. with the financial resources to pursue larger and more attractive acquisition targets. Access to capital is crucial for executing its growth strategy. Timeline: Ongoing.
- Restructuring Assets: Annabidiol Corp. could focus on acquiring and restructuring underperforming assets, improving their operational efficiency and profitability. The market for distressed assets is significant, providing opportunities for value creation. Timeline: Ongoing.
What Opportunities Does ACBD Have?
- Acquire a high-growth company in a promising sector.
- Form a strategic partnership with a well-established company.
- Capitalize on market trends and investor interest in specific industries.
What Threats Does ACBD Face?
- Inability to identify and execute successful acquisitions.
- Competition from other shell companies and SPACs.
- Changes in market conditions or regulatory environment.
What Are ACBD's Competitive Advantages?
- Access to capital for acquisitions.
- Network of potential partners and acquisition targets.
- Management expertise in deal-making (if applicable).
What Does ACBD Do?
Annabidiol Corp., formerly known as Asiana Dragons, was incorporated in 2009 and is based in Marblehead, Massachusetts. The company transitioned to its current name in January 2018. Historically, Annabidiol Corp. was involved in the telecommunications sector. However, it currently does not have significant operations. The company's present strategy revolves around identifying and engaging in asset acquisitions, strategic partnerships, and joint ventures. Annabidiol Corp. aims to collaborate with other companies to create value, though specific target industries or partnership criteria are not publicly detailed. The company's financial performance reflects its operational status, with a market capitalization of approximately $0.03 billion. The company's activities are within the financial services sector, specifically categorized as shell companies, which are often used for mergers, acquisitions, or raising capital without active business operations.
What Products and Services Does ACBD Offer?
- Focuses on asset acquisitions.
- Seeks strategic partnerships.
- Engages in joint ventures.
- Partners with other companies.
- Formerly operated in the telecommunications business.
- Currently has no significant operations.
How Does ACBD Make Money?
- Acquire assets or businesses.
- Form strategic alliances to create value.
- Generate returns through successful acquisitions or partnerships.
What Industry Does ACBD Operate In?
Annabidiol Corp. operates within the shell company segment of the financial services industry. Shell companies are often formed for the purpose of acquiring or merging with existing businesses, providing a vehicle for private companies to go public or for restructuring assets. The market for shell companies is driven by the demand for alternative routes to public listings and the availability of capital for acquisitions. The competitive landscape includes other shell companies and special purpose acquisition companies (SPACs), all vying for attractive acquisition targets. Given the lack of operational activity, Annabidiol Corp.'s success depends heavily on its ability to identify and execute value-accretive transactions in a competitive market.
Who Are ACBD's Key Customers?
- Target companies for acquisition.
- Potential partners for joint ventures.
- Investors seeking exposure to potential acquisitions.
Company Profile
Annabidiol Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Marblehead, US. The company is led by CEO Reginald T. Green. ACBD has traded publicly since 2018.
F-Score 0/9Financial Health
Annabidiol Corp.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -37.10 places it in the distress zone, a signal of elevated financial risk.
ROE 15%Key Financial Metrics
Return on equity for Annabidiol Corp. stands at 14.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -33.1%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.31 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.0%, the inverse of the P/E and a quick read on earnings relative to price.
ACBD Valuation & Market Position
With a $33.76M market cap, Annabidiol Corp. sits in the micro-cap segment of the market. Relative to its peer group, ACBD's quantitative score of 51/100 is roughly in line with the peer average of 59/100.
ACBD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Flexibility to pursue various acquisition opportunities.
- Potential for high returns if acquisitions are successful.
- Existing corporate structure and listing.
- Upcoming: Announcement of a strategic partnership or joint venture.
Bear Case
- Lack of current operations and revenue.
- Reliance on future acquisitions for growth.
- High dependence on management's deal-making abilities.
- Potential: Failure to identify and execute successful acquisitions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
ACBD Latest News
No recent news available for ACBD.
ACBD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ACBD.
Price Targets
Wall Street price target analysis for ACBD.
ACBD MoonshotScore
What does this score mean?
The MoonshotScore rates ACBD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Reginald T. Green
CEO
Reginald T. Green serves as the CEO of Annabidiol Corp. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data. Further research would be required to ascertain his specific expertise and qualifications.
Track Record: Due to the limited information available, Reginald T. Green's track record and key achievements as CEO of Annabidiol Corp. cannot be assessed. The company's lack of significant operations makes it difficult to evaluate his strategic decisions and impact on company milestones.
ACBD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Annabidiol Corp. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier are often speculative and carry significant risks due to limited information and regulatory oversight. Investing in OTC Other stocks is generally considered more risky than investing in stocks listed on major exchanges like the NYSE or NASDAQ, as these exchanges have stricter listing requirements and ongoing compliance standards.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited information and disclosure requirements.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher volatility compared to exchange-listed stocks.
- Greater risk of delisting or going out of business.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the management team's experience and track record.
- Understand the company's business plan and growth strategy.
- Evaluate the company's competitive position and industry outlook.
- Determine the company's capital structure and financing needs.
- Company is registered with the SEC (if applicable).
- Company has a functioning website and contact information.
- Company has a clear business plan and strategy.
- Company has a management team with relevant experience.
ACBD Financial Services Stock FAQ
What does Annabidiol Corp. do?
Annabidiol Corp. currently functions as a shell company, meaning it does not have significant ongoing business operations. Formerly involved in telecommunications, the company now focuses on identifying and executing asset acquisitions, strategic partnerships, and joint ventures. The company aims to acquire or merge with an existing business, providing a vehicle for restructuring assets or going public. Its success hinges on its ability to find and complete value-accretive transactions, transforming it from a shell company into an operating entity.
What do analysts say about ACBD stock?
Due to Annabidiol Corp.'s status as a shell company with limited operations, there is likely minimal to no analyst coverage. Traditional valuation metrics like revenue growth, earnings per share, and cash flow are not applicable in its current state. Any assessment of the stock would be highly speculative and based on the potential for future acquisitions or partnerships. Investors should conduct thorough due diligence and understand the risks associated with investing in a shell company.
What are the main risks for ACBD?
The primary risks for Annabidiol Corp. stem from its lack of current operations and reliance on future acquisitions. The company faces the risk of failing to identify and execute successful acquisitions, which would prevent it from becoming an operating entity. Competition from other shell companies and SPACs for attractive acquisition targets is also a significant risk. Changes in market conditions, regulatory environment, or investor sentiment could negatively impact its ability to raise capital or complete transactions. The limited information available and the speculative nature of its business model further contribute to the overall risk profile.
What are the key factors to evaluate for ACBD?
Annabidiol Corp. (ACBD) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does ACBD data refresh on this page?
ACBD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ACBD's recent stock price performance?
Annabidiol Corp. (ACBD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Flexibility to pursue various acquisition opportunities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ACBD overvalued or undervalued right now?
Valuing Annabidiol Corp. (ACBD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ACBD?
Before investing in Annabidiol Corp. (ACBD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Annabidiol Corp.'s current activities and future plans.
- Assessment based on available financial data and industry context.